Question 1

What is Rinvoq?

Accepted Answer

Rinvoq contains the active ingredient upadacitinib and belongs to a class of drugs known as Janus kinase (JAK) inhibitors. It works by interfering with specific signaling pathways in the body that contribute to inflammation and overactive immune responses.

By blocking these pathways, the medication helps to reduce the underlying processes that cause swelling, pain, and tissue damage in certain chronic conditions.

Question 2

What is Rinvoq used for?

Accepted Answer

Rinvoq is used to treat the following conditions:

Rheumatoid arthritis

Psoriatic arthritis

Ankylosing spondylitis

Others

Question 3

How does Rinvoq work?

Accepted Answer

Mechanism of Action

Rinvoq belongs to a class of medications known as Janus kinase (JAK) inhibitors. It works by interfering with the signaling pathways inside certain immune cells that contribute to inflammation.

Blocking Inflammatory Signals

In many autoimmune and inflammatory conditions, the body produces proteins called cytokines. These proteins attach to receptors on cell surfaces, which then use JAK enzymes to send a signal to the cell's nucleus to create more inflammation. Rinvoq specifically targets and blocks an enzyme called JAK1.

Reducing Immune Response

By blocking these signals, the medication helps to:

Decrease inflammation: It lowers the production of inflammatory substances that cause swelling and pain.

Regulate the immune system: It helps prevent the immune system from attacking the body's own healthy tissues, such as the joints, skin, or the lining of the digestive tract.

Because it targets a specific pathway within the immune system, it is considered a targeted therapy. This helps manage symptoms and prevent further damage caused by chronic inflammation in conditions like rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, and Crohn's disease.

Question 4

What are the active ingredients in Rinvoq?

Accepted Answer

The active ingredient in Rinvoq is upadacitinib .

Question 5

What are the side effects of Rinvoq?

Accepted Answer

Common side effects of Rinvoq may include:

upper respiratory tract infection

nausea

cough

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Rinvoq?

Accepted Answer

Rinvoq belongs to the JAK inhibitor drug class.

Question 7

What is the dosage of Rinvoq and how do I take it?

Accepted Answer

How to Take Rinvoq

Rinvoq is an extended-release tablet that is taken by mouth. It is typically prescribed to be taken once every day. You can take this medication regardless of whether you have eaten.

Administration Guidelines

Always swallow the tablet whole.

Do not split, crush, or chew the tablet, as this may interfere with how the medication is released into your body.

Try to take your dose at the same time each day to maintain a steady level of medicine in your system.

Missed Dose Instructions

If you forget to take a dose, take it as soon as you realize it. If it is nearly time for your next dose, skip the one you missed and return to your normal schedule. Never take a double dose to compensate for a missed one.

Question 8

Is Rinvoq safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Rinvoq may cause harm to a fetus if taken during pregnancy. Healthcare providers typically recommend that individuals who can become pregnant use effective birth control during treatment and for at least 4 weeks after the final dose. If you become pregnant while taking this medication, you should contact your doctor right away.

Breastfeeding

It is not known whether Rinvoq passes into breast milk. Because of the potential for serious side effects in a nursing child, breastfeeding is not recommended during treatment and for at least 6 days after the last dose. Patients should discuss feeding options and the risks and benefits of the medication with their healthcare provider.

Question 9

What forms and strengths does Rinvoq come in?

Accepted Answer

Rinvoq is supplied as an extended-release tablet. This formulation is designed to release the medication slowly after it is swallowed.

Administration

Rinvoq is taken by mouth.

The tablets must be swallowed whole.

Do not crush, chew, or break the tablets, as this can affect how the medication is released into the body.

Question 10

What is the FDA approval status of Rinvoq?

Accepted Answer

FDA Approval and Indications

Rinvoq was first approved by the U.S. Food and Drug Administration (FDA) in 2019. It is currently approved for use in adults with the following conditions:

Moderately to severely active rheumatoid arthritis

Active psoriatic arthritis

Atopic dermatitis (eczema)

Moderately to severely active ulcerative colitis

Moderately to severely active Crohn's disease

Active ankylosing spondylitis

Active non-radiographic axial spondyloarthritis

For many of these conditions, the FDA specifies that Rinvoq should be used only after one or more tumor necrosis factor (TNF) blockers have been tried and were not effective or could not be tolerated.

Boxed Warning

The FDA requires a Boxed Warning for Rinvoq, which is the agency's most serious type of warning. This warning is based on data showing that JAK inhibitors may increase the risk of:

Serious heart-related events, such as heart attack or stroke

Blood clots in the lungs, legs, or arteries

Certain types of cancer, including lymphoma and lung cancer

Serious infections that may lead to hospitalization or death

Increased risk of death, particularly in patients 50 years of age and older who have at least one cardiovascular risk factor

Regulatory Safety Communications

In 2021, the FDA issued a safety communication requiring updates to the Boxed Warning for Rinvoq and other JAK inhibitors. This regulatory action followed the review of a large safety clinical trial involving a similar medication in the same drug class. Although Rinvoq was not the specific drug in that trial, the FDA concluded it carries similar risks because of how it works in the body. Patients are advised to discuss their cardiovascular and cancer history with a healthcare provider before starting treatment.

Question 11

What should I know about Rinvoq and cost?

Accepted Answer

Estimated Pricing

Rinvoq is classified as a specialty medication. The list price for a 30-day supply of 15 mg, 30 mg, or 45 mg extended-release tablets is approximately $6,600 to $7,000. However, the actual out-of-pocket cost for most patients is typically lower than the list price.

Insurance and Coverage

Most private insurance plans and Medicare provide coverage for Rinvoq, though the specific copayment or coinsurance amount will vary. Because it is a high-cost specialty drug, insurance providers often require prior authorization. This process requires your healthcare provider to submit documentation to the insurance company to confirm that the medication is medically necessary for your condition.

Financial Assistance

There are several options available to help reduce the cost of Rinvoq:

Manufacturer Savings Cards: Patients with commercial insurance may be eligible for savings cards that significantly reduce monthly copayments.

Patient Assistance Programs: For individuals who are uninsured or underinsured, programs may be available to provide the medication at a reduced cost or for free, based on income eligibility and other requirements.

It is recommended to check with your insurance provider and specialty pharmacy to determine your specific costs and coverage requirements.

Rinvoq

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?